1.Effects of 12 Weeks High-Speed Elastic Band Training on Cognitive Function, Physical Performance and Muscle Strength in Older Women with Mild Cognitive Impairment: A Randomized Controlled Trial.
Dongheon KANG ; Heejae KIM ; Donghyun YOON ; Jinsoo KIM ; Wook SONG
Korean Journal of Health Promotion 2014;14(1):26-32
BACKGROUND: Exercise has shown to slow down the progression from mild cognitive impairment (MCI) to dementia. In particular, not only resistance exercise has been verified to improve physical performance and muscle strength, leading to the prevention of fall-related injuries in the frail elderly, but also cognitive function. In this study, we investigated how high-speed elastic band training, applied using a high-speed power training protocol, affects cognition, physical performance and muscle strength of female elderly individuals with MCI. METHODS: Thirty-nine subjects diagnosed with MCI from one senior college using a Korean version of mini-mental state examination (MMSE-K) and a Korean version of the Montreal Cognitive Assessment (MoCA-K) were randomly divided into exercise group (n=20) and control group (n=19). The exercise group completed a 12-week high-speed resistance elastic band exercise program and was encouraged to exercise at home as well during the intervention period. RESULTS: The results showed significant increases in cognitive function, physical performance and muscle strength assessed by digit span forward test (P<0.001), digit span backward test (P=0.003), the Stroop test B (P=0.031), SPPB scores (P=0.010), right knee 60degrees extensor peak torque (P=0.004), 60degrees flexor peak torque (P=0.001), 180degrees extensor peak torque (P=0.020) and grip strength (P=0.025). CONCLUSIONS: Our study showed that participants with MCI who continued the high-speed elastic band training program for 12 weeks showed improvements in cognitive function, physical performance and muscle strength.
Aged
;
Cognition
;
Dementia
;
Education
;
Female
;
Frail Elderly
;
Hand Strength
;
Humans
;
Knee
;
Mild Cognitive Impairment*
;
Muscle Strength*
;
Resistance Training
;
Stroop Test
;
Torque
2.Prevalence of Benign Prostatic Hyperplasia in Jeong-Eup Area: Community-based Study.
Tae Gyu CHUNG ; Jinsoo CHUNG ; Moo Song LEE ; Hanjong AHN
Korean Journal of Urology 1999;40(1):52-58
PURPOSE: There is no consensus about a definition of benign prostatic hyperplasia, but there are various definitions based on a combination of clinical parameters used to describe the properties of BPH: symptoms of prostatism, increase of prostate volume, and bladder outlet obstruction. The prevalence of clinical BPH in Asian was believed to be lower than Caucasian. The lower urinary tract symptoms associated with BPH in Korea was reported by some authors and it was similar to the results of other studies in western countries. We report the prevalence of BPH in Korean men through a community-based study in Jeong-Eup county, Korea. MATERIALS AND METHODS: A total of 653 men aged 50 and over in Jeong-Eup area, Korea was randomly selected for determination of the prevalence of BPH. The definition of BPH in this study was combination of moderate(8-19) to severe(>19) I-PSS, enlargement of the prostate over 30gms on digital rectal examination by one board certified urologist, and decreased peak flow rate below 15ml/sec. Men with abnormal digital rectal examination(DRE) and elevated serum prostate specific antigen(PSA) above 3.5ng/ml were undergone sextant prostate biopsy to exclude the prostate cancer. RESULTS: I-PSS questionnaires were completed in 431 men and the response rate was 66.1%. Based on I-PSS, 162 men(37.6%) had moderate symptoms and 51 men(11.9%) severe symptoms. Of 213 men with moderate to severe symptoms, 35.7% had enlarged prostate by DRE, and 63.1% decreased flow rate. The prevalence of BPH by the definition in this study was 4.3% in their fifties, 13.2% in sixties and 16.3% in seventies and over eighty(overall, 11.1%). The population-adjusted prevalence of BPH in Korean men aged 50 and over was 8.7%. A good correlation was found between the total symptom score and the quality of life score that is included in the I-PSS. CONCLUSIONS: Men with moderate to severe I-PSS was 49.5%, which was similar to the results from other studies in Caucasian and Japanese. The prevalence of BPH in Korea by aforementioned definition was 8.7%, which seems to be lower than Caucasian. This results suggest that approximately 1,600,000 Korean men had moderate to severe urinary symptoms and 300,000 clinical BPH by the definition in this study.
Asian Continental Ancestry Group
;
Biopsy
;
Consensus
;
Digital Rectal Examination
;
Humans
;
Jeollabuk-do*
;
Korea
;
Lower Urinary Tract Symptoms
;
Male
;
Prevalence*
;
Prostate
;
Prostatic Hyperplasia*
;
Prostatic Neoplasms
;
Prostatism
;
Quality of Life
;
Surveys and Questionnaires
;
Urinary Bladder Neck Obstruction
3.Asymptomatic Cervical or Thoracic Lesions in Elderly Patients who Have Undergone Decompressive Lumbar Surgery for Stenosis.
Boo Seop KIM ; Jinsoo KIM ; Han Sang KOH ; Song Yup HAN ; Dong Yeob LEE ; Kyeong Hwan KIM
Asian Spine Journal 2010;4(2):65-70
STUDY DESIGN: A retrospective study. PURPOSE: To evaluate the prevalence and risk factors of asymptomatic cervical or thoracic lesions in elderly patients who have undergone surgery for lumbar spinal stenosis. OVERVIEW OF LITERATURE: Concurrent multiple spinal lesions have been reported in many studies with a varied prevalence, and described the characteristics of the disease and its treatment options. However, the cervical or thoracic lesions without apparent symptoms in patients with symptomatic lumbar stenosis had not been evaluated. METHODS: A total of 101 elderly patients (aged 65 or more), who had undergone surgery for lumbar spinal stenosis from January 2005 to December 2005, were enrolled in this study. All patients underwent lumbar magnetic resonance imaging (MRI) along with T2-weighted cervical and thoracic sagittal MRI prior to surgery. The concurrent cervical or thoracic lesions were classified according to the disease entity, and the severity of the lesions was graded from grade 0 (no lesion) to grade 4 (any lesion compressing the cord with a signal change). The prevalence of concurrent cervical and thoracic lesions was then analyzed. In addition, the risk factors for the development of concurrent lesions were evaluated, and the risk factors affecting the severity of the concurrent lesion were analyzed individually. RESULTS: Seventy-seven (76.2%) and 30 (29.7%) patients had a concurrent cervical and thoracic lesion, respectively. Twenty-six patients (25.7%) had both a cervical and thoracic lesion. There was a positive correlation between the symptom duration of lumbar stenosis and the prevalence of both cervical (p = 0.044) and thoracic (p = 0.022) lesions. CONCLUSIONS: The incidence of asymptomatic cervical or thoracic lesions is apparently high in elderly patients who have undergone surgery for lumbar spinal stenosis, particularly in those with longer symptom duration. This highlights the need for a preoperative evaluation of the cervical and thoracic spine in these patients.
Aged
;
Constriction, Pathologic
;
Humans
;
Incidence
;
Magnetic Resonance Imaging
;
Prevalence
;
Retrospective Studies
;
Risk Factors
;
Spinal Stenosis
;
Spine
4.Prostate Cancer in a Patient with a Family History of BRCA Mutation: a Case Report and Literature Review.
Won Hoon SONG ; Sung Han KIM ; Jae Young JOUNG ; Weon Seo PARK ; Ho Kyung SEO ; Jinsoo CHUNG ; Kang Hyun LEE
Journal of Korean Medical Science 2017;32(2):377-381
One of the most significant risk factors for prostate cancer (PC) is a family history of the disease, with germ-line mutations in the breast cancer predisposition gene (BRCA) 2 conferring the highest risk. We here report a 56-year-old man presented with painful gait disturbance and diagnosed PC with multiple disseminated bone metastases. The patient had a strong family history of breast cancer with his 2 nieces affected. Furthermore, his aunts and uncles from both sides were diagnosed with stomach, ovarian, and colorectal cancers. His genomic sequencing analysis of the BRCA genes revealed the same BRCA2 deleterious mutation that his breast cancer-affected nieces carried. Previous studies have suggested that BRCA2-mutated PC is associated with a more aggressive phenotype and poor prognosis. Our experience in the present case also indicated the urgent needs for novel treatment modality and PC screening in this high-risk group of patients.
Breast
;
Breast Neoplasms
;
Colorectal Neoplasms
;
Gait
;
Germ-Line Mutation
;
Humans
;
Mass Screening
;
Middle Aged
;
Neoplasm Metastasis
;
Phenotype
;
Prognosis
;
Prostate*
;
Prostatic Neoplasms*
;
Risk Factors
;
Stomach
5.Low-Dose Bisphenol A Increases Bile Duct Proliferation in Juvenile Rats: A Possible Evidence for Risk of Liver Cancer in the Exposed Population?.
Ji Seong JEONG ; Ki Taek NAM ; Buhyun LEE ; Aryo Dimas PAMUNGKAS ; Daeun SONG ; Minjeong KIM ; Wook Joon YU ; Jinsoo LEE ; Sunha JEE ; Youngja H PARK ; Kyung Min LIM
Biomolecules & Therapeutics 2017;25(5):545-552
Increasing concern is being given to the association between risk of cancer and exposure to low-dose bisphenol A (BPA), especially in young-aged population. In this study, we investigated the effects of repeated oral treatment of low to high dose BPA in juvenile Sprague-Dawley rats. Exposing juvenile rats to BPA (0, 0.5, 5, 50, and 250 mg/kg oral gavage) from post-natal day 9 for 90 days resulted in higher food intakes and increased body weights in biphasic dose-effect relationship. Male mammary glands were atrophied at high dose, which coincided with sexual pre-maturation of females. Notably, proliferative changes with altered cell foci and focal inflammation were observed around bile ducts in the liver of all BPA-dosed groups in males, which achieved statistical significance from 0.5 mg/kg (ANOVA, Dunnett’s test, p<0.05). Toxicokinetic analysis revealed that systemic exposure to BPA was greater at early age (e.g., 210-fold in C(max), and 26-fold in AUC at 50 mg/kg in male on day 1 over day 90) and in females (e.g., 4-fold in C(max) and 1.6-fold in AUC at 50 mg/kg vs. male on day 1), which might have stemmed from either age- or gender-dependent differences in metabolic capacity. These results may serve as evidence for the association between risk of cancer and exposure to low-dose BPA, especially in young children, as well as for varying toxicity of xenobiotics in different age and gender groups.
Animals
;
Area Under Curve
;
Bile Ducts*
;
Bile*
;
Body Weight
;
Child
;
Female
;
Humans
;
Inflammation
;
Liver Neoplasms*
;
Liver*
;
Male
;
Mammary Glands, Human
;
Rats*
;
Rats, Sprague-Dawley
;
Toxicokinetics
;
Xenobiotics
6.Nasal and Pulmonary Toxicity of Titanium Dioxide Nanoparticles in Rats.
Soonjin KWON ; Young Su YANG ; Hyo Seon YANG ; Jinsoo LEE ; Min Sung KANG ; Byoung Seok LEE ; Kyuhong LEE ; Chang Woo SONG
Toxicological Research 2012;28(4):217-224
In recent decades, titanium dioxide (TiO2) nanoparticles have been used in various applications, including paints, coatings, and food. However, data are lacking on the toxicological aspects associated with their use. The aim of this study was to assess the inhalation toxicity of TiO2 nanoparticles in rats by using inhalation exposure. Male Wistar rats were exposed to TiO2 nanoparticles for 2 weeks (6 hr/day, 5 days/week) at a mean mass concentration of 11.39 +/- 0.31 mg/m3. We performed time-course necropsies at 1, 7, and 15 days after exposure. Lung inflammation and injury were assessed on the basis of the total and individual cell counts in bronchoalveolar lavage fluid (BALF), and by biochemical assays, including an assay for lactate dehydrogenase (LDH). Furthermore, histopathological examination was performed to investigate the lungs and nasal cavity of rats. There were no statistically significant changes in the number of BALF cells, results of biochemical assays of BALF and serum, and results of cytokine analysis. However, we did observe histopathological changes in the nasal cavity tissue. Lesions were observed at post-exposure days 1 and 7, which resolved at post-exposure day 15. We also calculated the actual amounts of TiO2 nanoparticles inhaled by the rats. The results showed that the degree of toxicity induced by TiO2 nanoparticles correlated with the delivered quantities. In particular, exposure to small particles with a size of approximately 20 nm resulted in toxicity, even if the total particle number was relatively low.
Animals
;
Bronchoalveolar Lavage Fluid
;
Cell Count
;
Humans
;
Inhalation
;
Inhalation Exposure
;
L-Lactate Dehydrogenase
;
Lung
;
Male
;
Nanoparticles
;
Nasal Cavity
;
Paint
;
Pneumonia
;
Rats
;
Rats, Wistar
;
Titanium
7.TiO2 nanotube stimulate chondrogenic differentiation of limb mesenchymal cells by modulating focal activity.
Dongkyun KIM ; Bohm CHOI ; Jinsoo SONG ; Sunhyo KIM ; Seunghan OH ; Eun Heui JIN ; Shin Sung KANG ; Eun Jung JIN
Experimental & Molecular Medicine 2011;43(8):455-461
Vertically aligned, laterally spaced nanoscale titanium nanotubes were grown on a titanium surface by anodization, and the growth of chondroprogenitors on the resulting surfaces was investigated. Surfaces bearing nanotubes of 70 to 100 nm in diameter were found to trigger the morphological transition to a cortical actin pattern and rounded cell shape (both indicative of chondrocytic differentiation), as well as the up-regulation of type II collagen and integrin beta4 protein expression through the down-regulation of Erk activity. Inhibition of Erk signaling reduced stress fiber formation and induced the transition to the cortical actin pattern in cells cultured on 30-nm-diameter nanotubes, which maintained their fibroblastoid morphologies in the absence of Erk inhibition. Collectively, these results indicate that a titanium-based nanotube surface can support chondrocytic functions among chondroprogenitors, and may therefore be useful for future cartilaginous applications.
Animals
;
Apoptosis
;
Cell Differentiation/*drug effects
;
Cells, Cultured
;
Chick Embryo
;
Chickens
;
Chondrocytes/cytology/drug effects/metabolism
;
Chondrogenesis/*drug effects
;
Collagen Type II/metabolism
;
Immunohistochemistry
;
Integrin beta4/metabolism
;
Mesenchymal Stem Cells/*cytology/*drug effects/metabolism
;
Nanotubes/*chemistry
;
Titanium/*chemistry/*pharmacology
8.Prostatectomy Provides Better Symptom-Free Survival Than Radiotherapy Among Patients With High-Risk or Locally Advanced Prostate Cancer After Neoadjuvant Hormonal Therapy
Sung Han KIM ; Mi Kyung SONG ; Weon Seo PARK ; Jae Young JOUNG ; Ho Kyung SEO ; Jinsoo CHUNG ; Kang Hyun LEE
Korean Journal of Urological Oncology 2018;16(3):126-134
PURPOSE: The purpose of this study is to compare the radiation therapy (RT) and radical prostatectomy (RP) of high-risk or locally advanced prostate cancer (PC) patients after neoadjuvant hormonal therapy (NHT). MATERIALS AND METHODS: This retrospective study evaluated patients underwent RT (42 patients) or RP (152 patients) after NHT at a single center during 2003–2014. Times to biochemical recurrence (BCR), pelvic local recurrence (PLR), metastasis, clinical painful symptom progression (CPSP), castration-resistant PC (CRPC), and overall survival were compared between the RT and RP groups, after adjustment for TN stage, using the Kaplan-Meier method and log-rank test. RESULTS: Significant inter-group differences were observed for age, Gleason score, initial PSA, and clinical and pathological T stages (all p < 0.05). During a median follow-up of 71.7 months, the overall incidences of BCR, PLR, metastasis, CPSP, CRPC, and death were 49.5%, 16.5%, 8.3%, 7.7%, 7.7%, and 17.5%, respectively. The median times to BCR were 100 months for RT and 36.2 months for RP (p=0.004), although the median times were not reached for the other outcomes (all p>0.05). The independent predictor of CPSP was RP (hazard ratio, 0.291; p=0.013). CONCLUSIONS: Despite significantly different baseline parameters, RP provided better CPSP-free survival than RT among patients with localized high-risk or locally advanced PC.
Follow-Up Studies
;
Humans
;
Incidence
;
Methods
;
Neoplasm Grading
;
Neoplasm Metastasis
;
Prostate
;
Prostatectomy
;
Prostatic Neoplasms
;
Radiotherapy
;
Recurrence
;
Retrospective Studies
;
Risk Factors
9.The Incidence Rate and Severity of Orthotopic Lung Cancer in an Animal Model Depends on the Number of A549 Cells and Transplantation Period.
Jinsoo LEE ; Young Ah HAN ; Hyo Seon YANG ; Jeong Ah SONG ; Young Su YANG ; Soonjin KWON ; Min Sung KANG ; Kyuhong LEE ; Jeong Doo HEO ; Kyu Hyuk CHO ; Chang Woo SONG
Laboratory Animal Research 2010;26(4):369-375
The incidence rate of lung cancer is continually increasing, and lung cancer is the leading cause of cancer-related death worldwide. Nevertheless, few therapeutic methods are available for lung cancer. Therefore, establishing appropriate lung cancer animal models is important to investigate mechanisms and to evaluate new drugs for lung cancer. In the present study, we transplanted non-small cell lung cancer A549 human adenocarcinoma cells (2x10(4), 2.0x10(5), and 2.0x10(6) cells) into the right lobe of BALB/c nude mice via the intercostal space to develop an orthotopic lung cancer animal model that is minimally invasive and similar to human lung cancer. We then investigated the incidence rate and severity of lung cancer according to the A549 cell number (2x10(4), 2.0x10(5), and 2.0x10(6) cells) and transplantation periods (4~23 days). Lung cancer development was confirmed with gross examination, which was supported by histopathological examination. These results indicate that the incidence rate and severity of lung cancer was increased depending on the number of transplanted cells and transplantation period which the cell number and duration are increasing risk of lung cancer. Thus, this study can provide appropriate reference data to develop an orthotopic lung cancer animal model using the non-small cell lung cancer A549 cell line for researching mechanisms and evaluating candidate drugs, including various approaches for treating lung cancer.
Adenocarcinoma
;
Animals
;
Carcinoma, Non-Small-Cell Lung
;
Cell Count
;
Cell Line
;
Humans
;
Incidence
;
Lung
;
Lung Neoplasms
;
Mice
;
Mice, Nude
;
Models, Animal
;
Transplants
10.Application of the International Metastatic Renal Cell Carcinoma Database Consortium and Memorial Sloan Kettering Cancer Center Risk Models in Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multi-Institutional Retrospective Study Using the Korean Metastatic Renal Cell Carcinoma Registry
Jung Kwon KIM ; Sung Han KIM ; Mi Kyung SONG ; Jungnam JOO ; Seong Il SEO ; Cheol KWAK ; Chang Wook JEONG ; Cheryn SONG ; Eu Chang HWANG ; Ill Young SEO ; Hakmin LEE ; Sung Hoo HONG ; Jae Young PARK ; Jinsoo CHUNG ;
Cancer Research and Treatment 2019;51(2):758-768
PURPOSE: The International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) and the Memorial Sloan Kettering Cancer Center (MSKCC) risk models were developed predominantly with clear cell renal cell carcinoma (RCC). Accordingly, whether these two models could be applied to metastatic non-clear cell RCC (mNCCRCC) as well has not been well-known and was investigated herein. MATERIALS AND METHODS: From the Korean metastatic RCC registry, a total of 156 patients (8.1%) with mNCCRCC among the entire cohort of 1,922 patients were analyzed. Both models were applied to predict first-line progression-free survival (PFS), total PFS, and cancer-specific survival (CSS). RESULTS: The median first-line PFS, total PFS, and CSS were 5, 6, and 24 months, respectively. The IMDC risk model reliably discriminated three risk groups to predict survival: the median first-line PFS, total PFS, and CSS for the favorable, intermediate, and poor risk groups were 9, 5, and, 2 months (p=0.001); 14, 7, and 2 months (p < 0.001); and 41, 21, and 8 months (p < 0.001), all respectively. The MSKCC risk model also reliably differentiated three risk groups: 9, 5, and, 2 months (p=0.005); 10, 7, and 3 months (p=0.002); and 50, 21, and 8 months (p < 0.001), also all respectively. The concordance indices were 0.632 with the IMDC model and 0.643 with the MSKCC model for first-line PFS: 0.748 and 0.655 for CSS. CONCLUSION: The current IMDC and MSKCC risk models reliably predict first-line PFS, total PFS, and CSS in mNCCRCC.
Carcinoma, Renal Cell
;
Cohort Studies
;
Disease-Free Survival
;
Humans
;
Prognosis
;
Retrospective Studies